Your cart is empty
Hepatitis NSW celebrates 10 years of Direct Acting Antivirals (DAAs) on the PBS
On 1 March 2016, Australians living with hep C gained equal access to interferon-free direct-acting antiviral (DAA) treatments, achieving cure rates exceeding 95%! You can read all about the campaigns and efforts that led up to this momentous announcement in our ‘Timeline to success’ >>
Hepatitis NSW hosted an event on Thursday, 19 March 2026 to mark a milestone that has shaped the successful drive to eliminate hepatitis C as a public health issue. The event celebrated the 10th anniversary of the listing of direct acting antivirals (DAAs) on the PBS.
Since listing in 2016, many thousands of people in NSW have been cured of hepatitis C. In addition, we have seen a significant drop in the prevalence and incidence of hepatitis C, especially in at-risk population groups.
Download the media release here >>
The event included the release of a series of video vox pops from people with lived experience of hepatitis C and DAA treatment, community members and leaders, health professionals, policy makers, allies and supporters reflecting on the campaign for, the achievement of, and impact of PBS listing of ‘gamechanger’ DAAs in 2016.
These videos will form a social media campaign promoting the efficacy and availability of hepatitis C treatment and cure. The campaign aims to create a fresh and renewed impetus to efforts in eliminating hepatitis C by 2030.
